-
1
-
-
28044432292
-
Autoimmune destruction of pancreatic beta cells
-
Yoon JW, Jun HS. Autoimmune destruction of pancreatic beta cells. Am J Ther. 2005;12:580-591.
-
(2005)
Am J Ther
, vol.12
, pp. 580-591
-
-
Yoon, J.W.1
Jun, H.S.2
-
2
-
-
49449104262
-
Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation
-
Huang X, Moore DJ, Ketchum RJ, et al. Resolving the conundrum of islet transplantation by linking metabolic dysregulation, inflammation, and immune regulation. Endocr Rev. 2008;29:603-630.
-
(2008)
Endocr Rev
, vol.29
, pp. 603-630
-
-
Huang, X.1
Moore, D.J.2
Ketchum, R.J.3
-
3
-
-
79952180946
-
Evolution of β-cell replacement therapy in diabetes mellitus: Pancreas transplantation
-
Jahansouz C, Kumer SC, Ellenbogen M, et al. Evolution of β-cell replacement therapy in diabetes mellitus: pancreas transplantation. Diabetes Technol Ther. 2011;13:395-418.
-
(2011)
Diabetes Technol Ther
, vol.13
, pp. 395-418
-
-
Jahansouz, C.1
Kumer, S.C.2
Ellenbogen, M.3
-
4
-
-
84867960499
-
Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation
-
Chhabra P, Brayman KL. Current status of immunomodulatory and cellular therapies in preclinical and clinical islet transplantation. J Transplant. 2011;2011:637-692.
-
(2011)
J Transplant.
, vol.2011
, pp. 637-692
-
-
Chhabra, P.1
Brayman, K.L.2
-
5
-
-
57349148359
-
Minimization and withdrawal of steroids in pancreas and islet transplantation
-
Mineo D, Sageshima J, Burke GW, et al. Minimization and withdrawal of steroids in pancreas and islet transplantation. Transplant Int. 2009;22:20-37.
-
(2009)
Transplant Int.
, vol.22
, pp. 20-37
-
-
Mineo, D.1
Sageshima, J.2
Burke, G.W.3
-
6
-
-
9644294263
-
Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus
-
DOI 10.1172/JCI200423235
-
Rother KI, Harlan DM. Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest. 2004;114:877-883. (Pubitemid 39578711)
-
(2004)
Journal of Clinical Investigation
, vol.114
, Issue.7
, pp. 877-883
-
-
Rother, K.I.1
Harlan, D.M.2
-
7
-
-
40749114425
-
Naturally occurring IgM anti-leukocyte autoantibodies (IgM
-
ALA) inhibit T cell activation and chemotaxis
-
Lobo PI, Schlegel KH, Spencer CE, et al. Naturally occurring IgM anti-leukocyte autoantibodies (IgM-ALA) inhibit T cell activation and chemotaxis. J Immunol. 2008;180:1780-1791.
-
(2008)
J Immunol.
, vol.180
, pp. 1780-1791
-
-
Lobo, P.I.1
Schlegel, K.H.2
Spencer, C.E.3
-
8
-
-
77956198729
-
Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis
-
Lobo PI, Schlegal KH, Vengal J, et al. Naturally occurring IgM anti-leukocyte autoantibodies inhibit T-cell activation and chemotaxis. J Clin Immunol. 2010;30(suppl 1):S31-S36.
-
(2010)
J Clin Immunol.
, vol.30
, Issue.SUPPL. 1
-
-
Lobo, P.I.1
Schlegal, K.H.2
Vengal, J.3
-
9
-
-
40749133411
-
Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoan-tibodies
-
Lobo PI, Schlegel KH, Yuan W, et al. Inhibition of HIV-1 infectivity through an innate mechanism involving naturally occurring IgM anti-leukocyte autoan-tibodies. J Immunol. 2008;180:1769-1779.
-
(2008)
J Immunol
, vol.180
, pp. 1769-1779
-
-
Lobo, P.I.1
Schlegel, K.H.2
Yuan, W.3
-
10
-
-
84863126294
-
Natural IgM anti-leukocyte autoanti-bodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17
-
Lobo PI, Bajwa A, Schlegel KH, et al. Natural IgM anti-leukocyte autoanti-bodies attenuate excess inflammation mediated by innate and adaptive immune mechanisms involving Th-17. J Immunol. 2012;188:1675-1785.
-
(2012)
J Immunol.
, vol.188
, pp. 1675-1785
-
-
Lobo, P.I.1
Bajwa, A.2
Schlegel, K.H.3
-
11
-
-
0033611137
-
Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome
-
Kerman RH, Susskind B, Buyse I, et al. Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome. Transplantation. 1999;68:1855-1858. (Pubitemid 30027337)
-
(1999)
Transplantation
, vol.68
, Issue.12
, pp. 1855-1858
-
-
Kerman, R.H.1
Susskind, B.2
Buyse, I.3
Pryzbylowski, P.4
Ruth, J.5
Warnell, S.6
Gruber, S.A.7
Katz, S.8
Van Buren, C.T.9
Kahan, B.D.10
-
12
-
-
0033608072
-
The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients
-
DOI 10.1097/00007890-199901270-00012
-
Przybylowski P, Balogna M, Radovancevic B, et al. The role of flow cytometry-detected IgG and IgM anti-donor antibodies in cardiac allograft recipients. Transplantation. 1999;67:258-262. (Pubitemid 29066351)
-
(1999)
Transplantation
, vol.67
, Issue.2
, pp. 258-262
-
-
Przybylowski, P.1
Balogna, M.2
Radovancevic, B.3
Frazier, O.H.4
Susskind, B.5
Van Buren, C.6
Katz, S.7
Kahan, B.D.8
Kerman, R.9
-
13
-
-
0034936968
-
Role of natural and immune IgM antibodies in immune responses
-
Boes M. Role of natural and immune IgM antibodies in immune responses. Mol Immunol. 2000;37:1141-1149.
-
(2000)
Mol Immunol.
, vol.37
, pp. 1141-1149
-
-
Boes, M.1
-
14
-
-
16344367291
-
Natural serum IgM maintains immunological homeostasis and prevents autoimmunity
-
DOI 10.1007/s00281-004-0187-x
-
Manson JJ, Mauri C, Ehrenstein MR. Natural serum IgM maintains im-munological homeostasis and prevents autoimmunity. Springer Semin Im-munopathol. 2005;26:425-432. (Pubitemid 40468894)
-
(2005)
Springer Seminars in Immunopathology
, vol.26
, Issue.4
, pp. 425-432
-
-
Manson, J.J.1
Mauri, C.2
Ehrenstein, M.R.3
-
15
-
-
77954930867
-
Adenosine A(2A) agonist administration improves islet transplant outcome: Evidence for the role of innate immunity in islet graft rejection
-
Chhabra P, Wang K, Zeng Q, et al. Adenosine A(2A) agonist administration improves islet transplant outcome: evidence for the role of innate immunity in islet graft rejection. Cell Transplant. 2010;19:597-612.
-
(2010)
Cell Transplant
, vol.19
, pp. 597-612
-
-
Chhabra, P.1
Wang, K.2
Zeng, Q.3
-
16
-
-
0031279105
-
CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice
-
Balasa B, Krahl T, Patstone G, et al. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J Immunol. 1997;159:4620-4627. (Pubitemid 127470625)
-
(1997)
Journal of Immunology
, vol.159
, Issue.9
, pp. 4620-4627
-
-
Balasa, B.1
Krahl, T.2
Patstone, G.3
Lee, J.4
Tisch, R.5
McDevitt, H.O.6
Sarvetnick, N.7
-
17
-
-
0028900297
-
Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse
-
Lenschow DJ, Ho SC, Sattar H, et al. Differential effects of anti-B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med. 1995;181:1145-1155.
-
(1995)
J Exp Med
, vol.181
, pp. 1145-1155
-
-
Lenschow, D.J.1
Ho, S.C.2
Sattar, H.3
-
19
-
-
66649113381
-
Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice
-
Emamaullee JA, Davis J, Merani S, et al. Inhibition of Th17 cells regulates autoimmune diabetes in NOD mice. Diabetes. 2009;58:1302-1311.
-
(2009)
Diabetes
, vol.58
, pp. 1302-1311
-
-
Emamaullee, J.A.1
Davis, J.2
Merani, S.3
-
20
-
-
77956398549
-
IL-17 immunity in human type 1 diabetes
-
Honkanen J, Nieminen JK, Gao R, et al. IL-17 immunity in human type 1 diabetes. J Immunol. 2010;185:1959-1967.
-
(2010)
J Immunol
, vol.185
, pp. 1959-1967
-
-
Honkanen, J.1
Nieminen, J.K.2
Gao, R.3
-
21
-
-
38749111445
-
Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production
-
DOI 10.1084/jem.20071878
-
Jain R, Tartar DM, Gregg RK, et al. Innocuous IFNgamma inducedbyadjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J Exp Med. 2008;205:207-218. (Pubitemid 351185727)
-
(2008)
Journal of Experimental Medicine
, vol.205
, Issue.1
, pp. 207-218
-
-
Jain, R.1
Tartar, D.M.2
Gregg, R.K.3
Divekar, R.D.4
Bell, J.J.5
Lee, H.-H.6
Yu, P.7
Ellis, J.S.8
Hoeman, C.M.9
Franklin, C.L.10
Zaghouani, H.11
-
22
-
-
78649983200
-
Immunotherapy of type 1 diabetes\how to rationally prioritize combination therapies in T1D
-
Boettler T, von Herrath M. Immunotherapy of type 1 diabetes\how to rationally prioritize combination therapies in T1D. Int Immunopharmacol. 2010;10:1491-1495.
-
(2010)
Int Immunopharmacol
, vol.10
, pp. 1491-1495
-
-
Boettler, T.1
Von Herrath, M.2
-
23
-
-
0027958044
-
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice
-
DOI 10.1073/pnas.91.1.123
-
Chatenoud L, Thervet E, Primo J, et al. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA. 1993;91:123-127. (Pubitemid 24018655)
-
(1994)
Proceedings of the National Academy of Sciences of the United States of America
, vol.91
, Issue.1
, pp. 123-127
-
-
Chatenoud, L.1
Thervet, E.2
Primo, J.3
Bach, J.-F.4
-
24
-
-
0023903295
-
Immunotherapy of the nonobese diabetic mouse; Treatment with an antibody to T helper lymphocytes
-
Shizuru JA, Taylor-Edwards C, Banks BA, et al. Immunotherapy of the nonobese diabetic mouse; treatment with an antibody to T helper lymphocytes. Science. 1988;240:659-662.
-
(1988)
Science
, vol.240
, pp. 659-662
-
-
Shizuru, J.A.1
Taylor-Edwards, C.2
Banks, B.A.3
-
25
-
-
0024232747
-
Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: Transfer of protection by splenic T cells
-
DOI 10.1073/pnas.85.24.9719
-
Boitard C, Bendelac A, Richard MF, et al. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc Natl Acad Sci USA. 1988;85:9719-9723. (Pubitemid 19027196)
-
(1988)
Proceedings of the National Academy of Sciences of the United States of America
, vol.85
, Issue.24
, pp. 9719-9723
-
-
Boitard, C.1
Bendelac, A.2
Richard, M.F.3
Carnaud, C.4
Bach, J.F.5
-
26
-
-
0025805116
-
Anti-a/b T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice
-
Sempe P, Bedossa P, Richard MF, et al. Anti-a/b T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. Eur J Immunol. 1991;21:1163-1169.
-
(1991)
Eur J Immunol
, vol.21
, pp. 1163-1169
-
-
Sempe, P.1
Bedossa, P.2
Richard, M.F.3
-
27
-
-
0027490359
-
Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors
-
DOI 10.1073/pnas.90.22.10494
-
Yang XD, Karin N, Tisch R, et al. Inhibition of insulitis and prevention of diabetes in nonobese diabetic mice by blocking L-selectin and very late antigen 4 adhesion receptors. Proc Natl Acad Sci USA. 1993;90:10494-10498. (Pubitemid 23347068)
-
(1993)
Proceedings of the National Academy of Sciences of the United States of America
, vol.90
, Issue.22
, pp. 10494-10498
-
-
Yang, X.-D.1
Karin, N.2
Tisch, R.3
Steinman, L.4
McDevitt, H.O.5
-
28
-
-
0028354067
-
Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM: Therapeutic intervention by immunostimulation?
-
Rabinovitch A. Immunoregulatory and cytokine imbalances in the patho-genesis of IDDM. Therapeutic intervention by immunostimulation. Diabetes. 1994;43:613-621. (Pubitemid 24138771)
-
(1994)
Diabetes
, vol.43
, Issue.5
, pp. 613-621
-
-
Rabinovitch, A.1
-
29
-
-
78049423506
-
An update on the use of NOD mice to study autoimmune (Type 1) diabetes
-
Chaparro RJ, Dilorenzo TP. An update on the use of NOD mice to study autoimmune (Type 1) diabetes. Expert Rev Clin Immunol. 2010;6:939-955.
-
(2010)
Expert Rev Clin Immunol.
, vol.6
, pp. 939-955
-
-
Chaparro, R.J.1
Dilorenzo, T.P.2
-
30
-
-
0029954214
-
Insulin-dependent diabetes mellitus
-
DOI 10.1016/S0092-8674(00)81106-X
-
Tisch R, McDevitt H. Insulin-dependent diabetes mellitus. Cell. 1996;85:291-297. (Pubitemid 26160699)
-
(1996)
Cell
, vol.85
, Issue.3
, pp. 291-297
-
-
Tisch, R.1
McDevitt, H.2
-
31
-
-
9244243051
-
Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions
-
DOI 10.1002/eji.200425141
-
Pakala SV, Bansal-Pakala P, Halteman BS, et al. Prevention of diabetes in NOD mice at a late stage by targeting OX40/OX40 ligand interactions. Eur J Immunol 2004;34:3039-3046. (Pubitemid 39549383)
-
(2004)
European Journal of Immunology
, vol.34
, Issue.11
, pp. 3039-3046
-
-
Pakala, S.V.1
Bansal-Pakala, P.2
Halteman, B.S.3
Croft, M.4
-
32
-
-
84860228482
-
Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lac-tococcus lactis in mice [published online ahead of print April 9, 2012]
-
doi:10.1172/JCI60530 Accessed April 19, 2012
-
Takiishi T, Korf H, Van Belle TL, et al. Reversal of autoimmune diabetes by restoration of antigen-specific tolerance using genetically modified Lac-tococcus lactis in mice [published online ahead of print April 9, 2012]. J Clin Invest. 2012;122:1717-1725. doi:10.1172/JCI60530. http://www.jci.org/ articles/view/60530#B22. Accessed April 19, 2012.
-
(2012)
J Clin Invest.
, vol.122
, pp. 1717-1725
-
-
Takiishi, T.1
Korf, H.2
Van Belle, T.L.3
-
34
-
-
33746896971
-
Costimulation blockade and its possible future use in clinical transplantation
-
DOI 10.1111/j.1432-2277.2006.00332.x
-
Snanoudj R, de Préneuf H, Créput C, et al. Costimulation blockade and its possible future use in clinical transplantation. Transplant Int. 2006;19:693-704. (Pubitemid 44196157)
-
(2006)
Transplant International
, vol.19
, Issue.9
, pp. 693-704
-
-
Snanoudj, R.1
De Preneuf, H.2
Creput, C.3
Arzouk, N.4
Deroure, B.5
Beaudreuil, S.6
Durrbach, A.7
Charpentier, B.8
-
35
-
-
77955965216
-
OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology
-
Ishii N, Takahashi T, Soroosh P, et al. OX40-OX40 ligand interaction in T-cell-mediated immunity and immunopathology. Adv Immunol. 2010;105:63-98.
-
(2010)
Adv Immunol
, vol.105
, pp. 63-98
-
-
Ishii, N.1
Takahashi, T.2
Soroosh, P.3
-
36
-
-
78650202203
-
Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis
-
Zhang Z, Zhong W, Hinrichs D, et al. Activation of OX40 augments Th17 cytokine expression and antigen-specific uveitis. Am J Pathol. 2010;177:2912-2920.
-
(2010)
Am J Pathol
, vol.177
, pp. 2912-2920
-
-
Zhang, Z.1
Zhong, W.2
Hinrichs, D.3
-
37
-
-
84863265179
-
Evolution of β-cell replacement therapy in diabetes mellitus: Islet cell transplantation
-
Jahansouz C, Jahansouz C, Kumer SC, et al. Evolution of β-cell replacement therapy in diabetes mellitus: islet cell transplantation. J Transplant. 2011;2011:247959.
-
(2011)
J Transplant.
, vol.2011
, pp. 247959
-
-
Jahansouz, C.1
Jahansouz, C.2
Kumer, S.C.3
|